Search clinical trials for: Astra Zeneca

Total 4626 results

National Research Centre, Egypt
Theodor Bilharz Research Institute; The holding company for biological products...

Recruiting

Comparative Study of Patterns of Immune Response to COVID 19 Vaccination

Immune Response to Covid 19 Vaccination

Egypt
Nanjing Medical University
Beijing Anzhen Hospital; Second Affiliated Hospital of Nanchang University

Recruiting

Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Thymosin α1) V

Acute Aortic Syndrome | Aortic Dissectio

China
Assistance Publique - Hôpitaux de Paris

Recruiting

Allergy and COVID-19 Vaccines (COVALL)

Vaccine Reaction | Anaphylactic Reaction

France
Canadian Immunization Research Network
Massachusetts General Hospital; CHU de Quebec-Universite Laval; McGill University... and other collaborators

Active, not recruiting

Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity (MOSAIC)

COVID-19

Canada
University of Washington
Eli Lilly and Company; Sanofi; Bayer; US Department of Veterans Affairs; University... and other collaborators

Completed

FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) (FLAT-SUGAR)

Type 2 Diabetes

United States
Jonsson Comprehensive Cancer Center
AstraZeneca

Active, not recruiting

Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy

Carcinoma, Non-Small-Cell Lung

United States, Australia
Vinbiocare Biotechnology Joint Stock Company
Arcturus Therapeutics, Inc.

Completed

The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01) (ARCT-154-01)

COVID-19 Vaccines

Vietnam
NCIC Clinical Trials Group
AstraZeneca

Completed

AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Pancreatic Cancer

Canada
Victoria Rollason

Active, not recruiting

PROGRESSive Withdrawal Esomeprazole and Acid-related Symptoms (PROGRESS)

Stomach Diseases

Switzerland
Serge Thal

Completed

Effect of Different SARS-CoV-2 Vaccine Schedules and Vaccination Intervals on Reactogenicity and Humoral Immunogenicity

SARS-CoV2 Infection | Tolerance | Immunisation Reaction | Antibody Hypersensitivity

Germany
National Taiwan University Hospital
Taoyuan General Hospital, Ministry of Health and Welfare,Taoyuan,Taiwan

Completed

Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination

Healthy Adult Volunteers

Taiwan
Thetis Pharmaceuticals LLC

Completed

PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA

Hypertriglyceridemia | Diabetes Mellitus, Non-Insulin-Dependent

United States
Asker & Baerum Hospital
Vestre Viken Hospital Trust; Helse Sor-Ost

Completed

Rate Control in Atrial Fibrillation II (RATAFII)

Atrial Fibrillation | Permanent Atrial Fibrillation

Norway
Chinese University of Hong Kong

Completed

The Interaction of Herbs and Statins

Drug Interaction

Hong Kong
Coordinación de Investigación en Salud, Mexico
Instituto Mexicano del Seguro Social; Hospital Infantil de Mexico Federico... and other collaborators

Completed

Efficacy of Betalactam Antibiotics in Prolonged Infusion Compared to Intermittent in Pediatric Patients With Sepsis

Sepsis

Mexico
University of Pecs

Enrolling by invitation

Plasma Concentration of Lidocaine and Bupivacaine Axillary BPB Mixture Solutions [PCLBAxMix] (PCLBAxMix)

Arm Injury

Hungary
AstraZeneca
Quintiles, Inc.

Completed

Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes

Type 2 Diabetes

United States, Korea, Republic of, India, Russian Federation, Brazil, Mexico, South Africa, Philippines
Steno Diabetes Center Copenhagen
Bayer; AstraZeneca; Rigshospitalet, Denmark; The Novo Nordic Foundation

Completed

The PRE-D Trial: Effect of Dapagliflozin, Metformin and Physical Activity in Pre-diabetes

Obesity | Prediabetic State

Denmark
Ostfold Hospital Trust

Unknown

Comparison of Two Induction Regimens Using Topical Lidocaine or Muscle Relaxant on Sore Throat and Hemodynamics

Intubation Complication

Norway
University of North Carolina, Chapel Hill
AstraZeneca; Medtronic

Completed

Intravenous Exenatide in Patients With Acute Brain Injury

Brain Injuries

United States
Fujian Cancer Hospital

Unknown

Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation (Geber)

Lung Adenocarcinoma | EGFR Mutation

China
Universiti Sains Malaysia

Completed

The Efficacy of 20 mg Parecoxib as an Adjunct to 0.75% Ropivacaine in Supraclavicular Brachial Plexus Block for Upper Limb Surgery (RCT)

Anesthesia | Anesthesia; Functional

Malaysia
Massachusetts General Hospital
National Cancer Institute (NCI); Dana-Farber Cancer Institute; AstraZeneca; Brigham...

Completed

Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy

Head and Neck Cancer

United States
University College, London
AstraZeneca

Terminated

Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Glioblastoma

United Kingdom
Medical University of Warsaw

Completed

Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method

Kidney Cancer | Anesthesia, Local | Surgery | Arrhythmia, Cardiac

Poland
AstraZeneca
Astra Zeneca, Bristol-Myers Squibb

Completed

Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg

Hypertension | Angina
University Health Network, Toronto
AstraZeneca

Completed

Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLC

LUNG CANCER

Canada
AstraZeneca
Astra Zeneca, Bristol-Myers Squibb

Completed

Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States, Netherlands, Canada
AstraZeneca
Astra Zeneca, Bristol-Myers Squibb

Completed

Add-on to Thiazolidinedione (TZD) Failures

Type 2 Diabetes

Taiwan, United States, Argentina, Canada, Mexico, Puerto Rico, Philippines, India, Peru
AstraZeneca
Astra Zeneca, Bristol-Myers Squibb

Completed

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

Type 1 Diabetes Mellitus

United States
Hopital Foch

Completed

Comparison of Different Propofol Formulations With or Without Remifentanil (PropofolRemi)

Anesthesia

France
GlaxoSmithKline

Completed

CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.

Asthma

Canada, Bulgaria, Estonia, Spain, Netherlands, Germany, Australia, Austria, Belgium, Finland, Ireland, Latvia, Macedonia, The Former Yugoslav Republic of, New Zealand, United Kingdom
Mikael Lantz

Completed

Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study) (aGO)

Graves´ Disease

Sweden
Indiana University
AstraZeneca

Completed

A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder Patients

Panic Disorder

United States
Medical University of Gdansk

Withdrawn

COGNITIVE - Cognitive Function After Sevoflurane or Propofol Anesthesia for Open-heart Operations

Memory Disorders | Other Functional Disturbances Following Cardiac Surgery

Poland
Baskent University

Completed

Effects of Dexmedetomidine Premedication on Geriatric Patients With Chronic Renal Failure Undergoing Hip Surgery

Hip Fracture | Chronic Renal Failure

Turkey
Pamukkale University

Completed

A Comparison of Efficacy of Intravenous Esomeprazole and Ranitidine Treatment of Dyspeptic Pain

Dyspepsia

Turkey
Duzce University

Completed

Caudal Block With Tramadol and Levobupivacaine or Bupivacaine

Pain, Postoperative

Turkey
AstraZeneca

Unknown

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Lung Cancer

United States
AstraZeneca

Unknown

ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Lung Cancer

United States
Dexa Medica Group

Completed

Bioequivalence Study of Two Formulations of 10 mg Lisinopril Tablet Under Fasting Condition

Healthy

Indonesia
Great Ormond Street Hospital for Children NHS Foundation...

Completed

Blood Propofol Concentrations in Children During Spinal Surgery

Idiopathic Scoliosis | Spine Deformities | Neuromuscular Dystrophy

United Kingdom
AstraZeneca

Completed

ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
Barbara Ann Karmanos Cancer Institute
AstraZeneca

Withdrawn

Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer
British Columbia Cancer Agency
AstraZeneca

Completed

Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol

Lung Cancer | Precancerous Condition

Canada
AstraZeneca

Completed

A Bioequivalence Study to Compare VIMOVO Manufactured at AstraZenca AB to VIMOVO Manufactured by Patheon Pharmaceuticals and Marketed Enteric-coated Naproxen Formulation

Healthy Volunteers | Bioequivalence

United Kingdom
Southern Arizona VA Health Care System

Unknown

Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD (ISS)

Gastroesophageal Reflux Disease

United States
Medical University of Gdansk

Completed

Desflurane Versus Propofol Anesthesia for Off-Pump CABG

Coronary Artery Disease

Poland
AstraZeneca

Not yet recruiting

A PROSPECTIVE, MULTI-CENTER, PHASE 4 STUDY TO ASSESS THE SAFETY OF TRASTUZUMAB DERUXTECAN, AN ANTI-HER2-ANTIBODY DRUG CONJUGATE IN INDIAN PATIENTS WITH UNRESECTABLE OR METASTATIC HER2-POSITIVE BREAST CANCER WHO HAVE RECEIVED A PRIOR ANTI-HER2-BASED REGIMEN (STRIDE)

BREAST CANCER

Search clinical trials for: Astra Zeneca

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations